News

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami

read more
2560 1958 Anemocyte
Anemocyte brings Italian excellence in the Cell and Gene Therapy sector to Phacilitate Leaders World 2020 in Miami

Anemocyte brings Italian excellence in the Cell and Gene Therapy sector to Phacilitate Leaders World 2020 in Miami

At the cutting edge of Cell and Gene therapy and a centre of excellence for the production of plasmids and non-viral solutions for genetic modifications, Anemocyte will be a key player at the leading sector event thanks to its expertise, dynamism and industrial cell and plasmid manufacturing facilities

read more
2560 1315 Anemocyte
Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

The Italian biotech Genenta Science has raised €13.2M in a private round to fund two ongoing phase I/II trials of its stem cell therapy Temferon for blood and brain cancer

read more
1610 792 Anemocyte
Anemocyte to expand its plasmid manufacturing capabilities

Anemocyte to expand its plasmid manufacturing capabilities

A new state-of-the-art facility dedicated to plasmid manufacturing will be in operation by August 2019 in Gerenzano, Italy. The new site will couple with the existing GMP facility active in the Cell and Gene (C&G) therapy space. With 800m2 (8,000 square feet) of cleanrooms, the two facilities of Anemocyte, the first Biotech Manufacturing Organisation (BMO), will address manufacturing needs of Somatic Cells, Non-Viral Modified Cells, Vesicles and Plasmids for Viral Vectors

read more
1200 450 Anemocyte
Drones Land in the Cell and Gene Therapy Space

Drones Land in the Cell and Gene Therapy Space

Cell and gene therapies could be flying high soon, joining the medical supplies, whole blood products, and even organs being transported by drones. In collaboration with RPS Aerospace, the Italy-based biotech company Anemocyte developed a remotely piloted drone system to securely transport final cell and gene therapy products from manufacturing sites to clinical centers

read more
2560 1556 Anemocyte

Technology Review: Gene Editing

Edition one of Phacilitate’s Technology review series examines gene editing approaches by viral and no-viral methods and where to access these services

read more
150 150 Anemocyte
The Power of Perseverance: How Dendreon Bounced Back

The Power of Perseverance: How Dendreon Bounced Back

The discussion moves onto goes onto the fine line between success and failure, examining the stories of Apollo 13, Thomas Edison and Elizabeth Gilbert, the author of Eat. Pray. Love. Dwayne explores failure and its negative connotations. Failure provides an opportunity to learn and to display passion to others, it’s an iteration on the road to success. In the immortal words of the great Thomas Edison

read more
2560 1556 Anemocyte
Cell and gene thrapy (CGT) manufacturing boom roars along

Cell and gene thrapy (CGT) manufacturing boom roars along

With a swell of R&D activity flowing into the development of cell and gene therapies over the past decade, a manufacturing shortage gripped the industry. This caused industry participants to express grave fears that the manufacturing shortage would threaten industry growth and lengthen time-to-market for these new types of living therapies

read more
1200 450 Anemocyte
Bluebird bio’s first gene therapy wins approval in Europe

Bluebird bio’s first gene therapy wins approval in Europe

Bluebird Bio Inc.’s first gene therapy, a treatment for an inherited blood disorder, was cleared by European Union regulators, another milestone for the field following U.S. approval of Novartis AG’s $2.1 million treatment for a lethal childhood disease

read more
1200 450 Anemocyte

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961